{"id":972,"date":"2011-02-15T00:00:00","date_gmt":"2011-02-15T00:00:00","guid":{"rendered":"http:\/\/www.innovationanthology.com\/import\/2018\/02\/01\/innovation-anthology-376\/"},"modified":"2018-02-25T21:30:23","modified_gmt":"2018-02-25T21:30:23","slug":"innovation-anthology-376","status":"publish","type":"post","link":"https:\/\/www.innovationanthology.com\/import\/2011\/02\/15\/innovation-anthology-376\/","title":{"rendered":"Innovation Anthology #376:"},"content":{"rendered":"<p><a href=\"http:\/\/innovationanthology.com\/uploads\/Innovation Anthology 376.mp3\">Download MP3 Link<\/a><\/p>\n<p>\nNot only is the absence of the <b>RASS F1<\/b> gene linked to cancer, it\u2019s also linked to <b>chronic inflammation. <\/b>\n<\/p>\n<p>\nUniversity of Alberta researcher <b>Dr. Shairaz Baksh<\/b> is studying the link in patients with <b>inflammatory bowel disease.<\/b>\n <\/p>\n<p><b><br \/>\nDR. SHAIRAZ BAKSH:<\/b><em>   Inflammatory bowel disease has two forms, ulcerative colitis and Crohns disease which are two very prominent diseases in Alberta.  We now know in these patients  if they have chronic inflammation which is persistent inflammation they can get predisposed to getting colon cancer, colorectal cancer,  later in life.   And for kids, there\u2019s definitely a predisposition to getting what\u2019s called B cell lymphomas or cancers of the blood.<br \/>\nAnd so we\u2019re quite interested in understanding inflammation because our idea is that if we can understand and control the inflammation at an earlier step,  we can certainly prevent these patients from getting another disease \u2013 cancer &#8211; later in life.   So we\u2019re very interested in that and we now have a gene that\u2019s involved in cancer and inflammation that we can now understand the link between cancer and inflammation.  <\/em>\n<\/p>\n<p>\nDr. Baksh is researching the use of <b>resviritrol,<\/b> a compound in red wine, as a treatment to turn the RASS F1 gene back on.  This could prevent both chronic inflammation and the formation of cancer.\n<\/p>\n<p><em><br \/>\nThanks today to <b>Alberta Innovates Health Solutions<\/em>\n<\/p>\n<p>\nFOR INNOVATION ANTHOLOGY<br \/>\nI\u2019M CHERYL CROUCHER <\/b>\n<\/p>\n<h2>Guest<\/h2>\n<h3> , <\/h3>\n<h4>, , , , <\/h4>\n<h2>Sponsor<\/h2>\n<h3><a href=\"http:\/\/www.aihealthsolutions.ca\">Alberta Innovates Health Solutions<\/a><\/h3>\n<p><font size=\"3\"><span style=\"font-weight: bold;\">Alberta Innovates (formerly Alberta Innovates &ndash; Health Solutions) <\/span><\/font><\/p>\n<p>As the newly formed Alberta Innovates corporation, we still fund top  quality, internationally competitive health&nbsp;research and innovation  activities to improve the health and wellbeing of Albertans.&nbsp;We provide  leadership for Alberta&rsquo;s health research and&nbsp;innovation enterprise by  directing, coordinating, reviewing, funding and supporting&nbsp;research and  innovation.<\/p>\n<p>Working&nbsp;with our many partners&nbsp; in the health system, we ensure that research achieves innovation  in&nbsp;care, policy and practice, and that the needs of patients and  clinicians influence&nbsp;research.<\/p>\n<h3>Our&nbsp;background<\/h3>\n<p><a href=\"http:\/\/albertainnovates.ca\/\" target=\"_blank\">Alberta Innovates<\/a> consolidation was launched November 1, 2016.<\/p>\n<p><strong>Alberta Innovates &ndash; Health Solutions<\/strong><\/p>\n<p>Alberta Innovates &ndash; Health Solutions was established as part of the Alberta Innovates system by an Act of Legislation of the Government of Alberta. It is a agency&nbsp;  of the Government of Alberta.&nbsp;We receive a yearly allocation from the  Ministry of Health and report through the ministry to the people of  Alberta.<\/p>\n<p>Our Mandate and Roles document reflects our role and responsibilities and outlines the government statues and regulations with which we comply.<\/p>\n<p>Alberta&rsquo;s Health Research and Innovation Strategy (AHRIS) sets out  Alberta&rsquo;s health research agenda for the coming decade to ensure our  considerable investments in research align with our priority&mdash;to improve  the health of Albertans.<\/p>\n<p>&nbsp;<\/p>\n<div class=\"et_pb_module et-waypoint et_pb_image et_pb_animation_off et_pb_image_3 et_always_center_on_mobile et_pb_image_sticky et-animated\"> \t\t\t\t<img decoding=\"async\" alt=\"\" src=\"http:\/\/albertainnovates.ca\/wp-content\/uploads\/2016\/10\/health_solutions_v2_icon.png\" \/> \t\t\t \t\t\t<\/div>\n<div class=\"et_pb_text et_pb_module et_pb_bg_layout_light et_pb_text_align_left  et_pb_text_2\">\n<p><strong>780-423-5727<br \/>Toll free: 1-877-423-5727<br \/><a href=\"http:\/\/aihealthsolutions.ca\">aihealthsolutions.ca<\/a><\/strong><\/p>\n<p>1500,<br \/>10104 &ndash; 103 Avenue<br \/>Edmonton, Alberta, Canada<br \/>T5J 4A7<\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"http:\/\/innovationanthology.com\/uploads\/AI Health_AHFMR Tagline_RGB.jpg\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Program Date:<\/strong>\u00a02011-02-15<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Not only is the absence of the <b>RASS F1<\/b> gene linked to cancer, it\u2019s also linked to <b>chronic inflammation.<\/b>     University of Alberta researcher <b>Dr. Shairaz Baksh<\/b> is studying the link in patients with inflammatory bowel disease.  And surprise, an activite ingredient in red wine holds promise for treatment. <em> (Alberta Innovates Health Solutions)<\/em><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55,7,2],"tags":[],"class_list":["post-972","post","type-post","status-publish","format-standard","hentry","category-alberta-innovates-health-solutions","category-genomics","category-health-and-medicine","has-post-title","has-post-date","has-post-category","has-post-tag","has-post-comment","has-post-author",""],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/comments?post=972"}],"version-history":[{"count":3,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/972\/revisions"}],"predecessor-version":[{"id":4694,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/posts\/972\/revisions\/4694"}],"wp:attachment":[{"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/media?parent=972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/categories?post=972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innovationanthology.com\/import\/wp-json\/wp\/v2\/tags?post=972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}